The mutation pattern of IRF8 in DLBCL (and related B cell malignancies) is similar to that of CREBBP, EP300, KMT2D, and TET2, among other genes (12, 13, 36, 37). Here, KMT2D is linked to diffuse large B-cell lymphoma.